Pless_2011_Mol.Pharmacol_79_742

Reference

Title : A cation-pi interaction at a phenylalanine residue in the glycine receptor binding site is conserved for different agonists - Pless_2011_Mol.Pharmacol_79_742
Author(s) : Pless SA , Hanek AP , Price KL , Lynch JW , Lester HA , Dougherty DA , Lummis SC
Ref : Molecular Pharmacology , 79 :742 , 2011
Abstract :

Cation-pi interactions have been demonstrated to play a major role in agonist-binding in Cys-loop receptors. However, neither the aromatic amino acid contributing to this interaction nor its location is conserved among Cys-loop receptors. Likewise, it is not clear how many different agonists of a given receptor form a cation-pi interaction or, if they do, whether it is with the same aromatic amino acid as the major physiological agonist. We demonstrated previously that Phe159 in the glycine receptor (GlyR) alpha1 subunit forms a strong cation-pi interaction with the principal agonist, glycine. In the current study, we investigated whether the lower efficacy agonists of the human GlyR beta-alanine and taurine also form cation-pi interactions with Phe159. By incorporating a series of unnatural amino acids, we found cation-pi interactions between Phe159 and the amino groups of beta-alanine and taurine. The strengths of these interactions were significantly weaker than for glycine. Modeling studies suggest that beta-alanine and taurine are orientated subtly differently in the binding pocket, with their amino groups further from Phe159 than that of glycine. These data therefore show that similar agonists can have similar but not identical orientations and interactions in the binding pocket and provide a possible explanation for the lower potencies of beta-alanine and taurine.

PubMedSearch : Pless_2011_Mol.Pharmacol_79_742
PubMedID: 21266487

Related information

Citations formats

Pless SA, Hanek AP, Price KL, Lynch JW, Lester HA, Dougherty DA, Lummis SC (2011)
A cation-pi interaction at a phenylalanine residue in the glycine receptor binding site is conserved for different agonists
Molecular Pharmacology 79 :742

Pless SA, Hanek AP, Price KL, Lynch JW, Lester HA, Dougherty DA, Lummis SC (2011)
Molecular Pharmacology 79 :742